Loading…
CorMedix Inc. is projected to rise to $10.95 by 2027, a +45% move from its current price of $7.53. CRMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $7.34 | $7.54 | $7.74 | +0.08% |
| Aug 3 | $7.27 | $7.54 | $7.83 | +0.17% |
| Aug 4 | $7.21 | $7.55 | $7.90 | +0.25% |
| Aug 5 | $7.17 | $7.55 | $7.97 | +0.33% |
| Aug 6 | $7.13 | $7.56 | $8.02 | +0.41% |
| Aug 7 | $7.09 | $7.57 | $8.07 | +0.50% |
| Aug 8 | $7.06 | $7.57 | $8.12 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.06 | $7.57 | $8.12 | +0.58% |
| Week 2 | $6.90 | $7.62 | $8.41 | +1.16% |
| Week 3 | $6.79 | $7.66 | $8.65 | +1.75% |
| Week 4 | $6.70 | $7.71 | $8.86 | +2.34% |
| Week 5 | $6.63 | $7.75 | $9.06 | +2.93% |
| Week 6 | $6.57 | $7.80 | $9.25 | +3.52% |
| Week 7 | $6.52 | $7.84 | $9.44 | +4.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.
CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
CorMedix Inc. (CRMD) is trading at $7.19 per share, has a market capitalization of $564.07M, and is ranked 2938.
The 2026 forecast shows min $6.25, avg $7.19, max $10.45 with NEUTRAL sentiment.
From 2027 onward, the forecast is BULLISH, with average prices advancing to $14.66 by 2030 and $93.91 by 2050, while max prices rise to $21.22 in 2030, $85.12 in 2040, and $172.46 in 2050. The corresponding ROIs are 103.9, 604.7, and 1206.2 respectively.
A major floor 17.9% below — a decisive break under it would weaken the trend.
The nearest floor, 4.5% below — buyers have tended to step in here.
The nearest ceiling, 17.8% above — a clean break opens room to run.
A major ceiling 26.7% above — clearing it would confirm fresh momentum.
Key CRMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.43 | Buy | $7.52 | Buy |
| MA 10 | $7.70 | Sell | $7.69 | Sell |
| MA 20 | $8.11 | Sell | $7.92 | Sell |
| MA 50 | $8.28 | Sell | $8.06 | Sell |
| MA 100 | $7.74 | Sell | $8.13 | Sell |
| MA 200 | $8.64 | Sell | $8.58 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.10 | Neutral |
| Stoch RSI (14) | 43.55 | Neutral |
| CCI (20) | -92.15 | Neutral |
| Williams %R (14) | -72.36 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | -10.57 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 27.64 | Neutral |
| TRIX (15) | -0.27 | Sell |
| Awesome (5,34) | -0.79 | Sell |
| Ultimate (7,14,28) | 35.92 | Neutral |
| Momentum (10) | -0.89 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 7.24 | Buy |
| ADX (14) | 16.02 | Neutral |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30. The 50-day simple moving average is $8.29 and the 200-day simple moving average is $8.67.
Support sits at $7.19 and resistance at $8.87. The 30-day range spans from $6.02 to $8.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.25 | $7.53 | $10.96 | 0% | Neutral | |
| $8.75 | $10.95 | $14.45 | +45% | Bullish | |
| $9.57 | $12.30 | $16.84 | +63% | Bullish | |
| $11.20 | $14.72 | $20.74 | +95% | Bullish | |
| $11.79 | $15.81 | $22.81 | +110% | Bullish | |
| $12.74 | $17.38 | $25.61 | +131% | Bullish | |
| $15.61 | $21.66 | $32.52 | +188% | Bullish | |
| $18.21 | $25.67 | $39.20 | +241% | Bullish | |
| $21.46 | $30.70 | $47.61 | +308% | Bullish | |
| $23.02 | $33.41 | $52.57 | +344% | Bullish | |
| $36.58 | $56.62 | $94.65 | +652% | Bullish | |
| $61.87 | $106.92 | $195.24 | +13.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $6.25 | $7.53 | $9.48 | +0.00% |
| September 2026 | $6.76 | $8.00 | $9.71 | +6.19% |
| October 2026 | $6.82 | $8.12 | $9.97 | +1.53% |
| November 2026 | $7.14 | $8.54 | $10.57 | +5.17% |
| December 2026 | $7.31 | $8.79 | $10.96 | +2.91% |
Click any year to see its month-by-month CRMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CRMD is projected to trade between $6.25 and $10.96, averaging $7.53 — a potential gain of 0% from today's $7.53. A consolidation phase looks the most probable path here.
CorMedix Inc.'s 2027 outlook centres on $10.95, within a $8.75 to $14.45 range. That is up +45% on the projected 2026 average. That marks a +45% change versus current levels. Momentum favours further upside here.
By 2028, CRMD could reach as high as $16.84, with a base case around $12.30 and support toward $9.57 — roughly +63% from $7.53. Buyers look set to stay in control over this stretch.
Expect CRMD to range from $11.20 to $20.74 through 2029. The $14.72 average target implies a +95% move from current prices. That is up +20% on the projected 2028 average. Momentum favours further upside here.
The CRMD price prediction for 2030 points to an average of $15.81 (low $11.79, high $22.81) — a potential gain of +110% on today's $7.53. Buyers look set to stay in control over this stretch.
In 2031, CRMD is projected to trade between $12.74 and $25.61, averaging $17.38 — a potential gain of +131% from today's $7.53. That is up +10% on the projected 2030 average. Momentum favours further upside here.
CorMedix Inc.'s 2032 outlook centres on $21.66, within a $15.61 to $32.52 range. That is up +25% on the projected 2031 average. That marks a +188% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CRMD could reach as high as $39.20, with a base case around $25.67 and support toward $18.21 — roughly +241% from $7.53. Momentum favours further upside here.
Expect CRMD to range from $21.46 to $47.61 through 2034. The $30.70 average target implies a +308% move from current prices. That is up +20% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CRMD price prediction for 2035 points to an average of $33.41 (low $23.02, high $52.57) — a potential gain of +344% on today's $7.53. Momentum favours further upside here.
In 2040, CRMD is projected to trade between $36.58 and $94.65, averaging $56.62 — a potential gain of +652% from today's $7.53. That is up +69% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CorMedix Inc.'s 2050 outlook centres on $106.92, within a $61.87 to $195.24 range. That is up +89% on the projected 2040 average. That marks a +13.2x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CRMD today (≈ 132.802125 CRMD) could be worth
$14,199.61
+$13,199.61 (+1320%) by 2050 · US Dollar
Based on the average projected CRMD price of $106.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRMDwould be worth at today's price.
$1,000 invested in CRMD on Jul 31, 2025 (≈ 85.689802 CRMD) would be worth
$645.24
-$354.76 (-35.5%) today · 0.65× · US Dollar
Based on a CRMD entry price of $11.67 vs. today's $7.53.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.87 | $956.8 | -4.3% |
| 1 month ago | $8.47 | $889.02 | -11.1% |
| 3 months ago | $7.79 | $966.62 | -3.3% |
| 6 months ago | $8.17 | $921.66 | -7.8% |
| 1 year ago | $11.67 | $645.24 | -35.5% |
| All time (5.0y) ago | $6.01 | $1,252.91 | +25.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRMD forecast.
Our base-case forecast reaches $15.00 around 2030.
Implied market cap at $15.00: $1.18B
The multi-year forecast shows a bullish trajectory from 2027 onward, with rising average prices and expanding ROIs. For 2027, the avg is $10.37 with an ROI of 44.2 and a BULLISH sentiment; for 2030 the avg is $14.66 with an ROI of 103.9 and a BULLISH sentiment.
Longer-run milestones include 2040 with an avg of $50.67 (ROI 604.7) and 2050 with an avg of $93.91 (ROI 1206.2), both Bullish. The max forecast values align with this trend, reaching $21.22 in 2030, $85.12 in 2040, and $172.46 in 2050. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $14.66; min $10.91; max $21.22; ROI 103.9; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs, including 2027 avg $10.37 (ROI 44.2%), 2030 ROI 103.9%, 2040 ROI 604.7%, and 2050 ROI 1206.2%.
Yes—the 2050 max is $172.46 with an average of $93.91 and a bullish sentiment.
RSI14 is 30, SMA50 is $8.29, SMA200 is $8.67. Support is $7.19 and resistance is $8.87; the 30-day range is $6.02 to $8.58.
Current price is $7.19 and market cap is $564.07M.
CorMedix Inc. Community Discussion
0Share your CorMedix Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.